Annual FCF:
-$604.32M-$273.69M(-82.78%)Summary
- As of today, ARWR annual free cash flow is -$604.32 million, with the most recent change of -$273.69 million (-82.78%) on September 30, 2024.
- During the last 3 years, ARWR annual free cash flow has fallen by -$752.07 million (-509.03%).
- ARWR annual free cash flow is now -475.27% below its all-time high of $161.03 million, reached on September 30, 2019.
Performance
ARWR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$152.08M-$606.84M(-133.44%)Summary
- As of today, ARWR quarterly free cash flow is -$152.08 million, with the most recent change of -$606.84 million (-133.44%) on June 30, 2025.
- Over the past year, ARWR quarterly free cash flow has dropped by -$22.22 million (-17.11%).
- ARWR quarterly free cash flow is now -133.44% below its all-time high of $454.76 million, reached on March 31, 2025.
Performance
ARWR Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$17.62M-$22.22M(-483.40%)Summary
- As of today, ARWR TTM free cash flow is -$17.62 million, with the most recent change of -$22.22 million (-483.40%) on June 30, 2025.
- Over the past year, ARWR TTM free cash flow has increased by +$514.36 million (+96.69%).
- ARWR TTM free cash flow is now -110.54% below its all-time high of $167.24 million, reached on June 30, 2021.
Performance
ARWR TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ARWR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -82.8% | -17.1% | +96.7% |
| 3Y3 Years | -509.0% | -94.0% | +85.3% |
| 5Y5 Years | -475.3% | -327.6% | +83.6% |
ARWR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -219.9% | at low | -133.4% | +18.4% | -483.4% | +97.1% |
| 5Y | 5-Year | -509.0% | at low | -133.4% | +18.4% | -110.5% | +97.1% |
| All-Time | All-Time | -475.3% | at low | -133.4% | +18.4% | -110.5% | +97.1% |
ARWR Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$152.08M(-133.4%) | -$17.62M(-483.4%) |
| Mar 2025 | - | $454.76M(+386.4%) | $4.60M(+100.8%) |
| Dec 2024 | - | -$158.79M(+1.7%) | -$576.61M(+4.6%) |
| Sep 2024 | -$604.32M(-82.8%) | -$161.50M(-24.4%) | -$604.32M(-13.6%) |
| Jun 2024 | - | -$129.87M(-2.7%) | -$531.98M(-13.1%) |
| Mar 2024 | - | -$126.45M(+32.2%) | -$470.16M(-16.8%) |
| Dec 2023 | - | -$186.50M(-109.2%) | -$402.70M(-21.8%) |
| Sep 2023 | -$330.63M(-75.0%) | -$89.16M(-31.0%) | -$330.63M(+3.6%) |
| Jun 2023 | - | -$68.05M(-15.4%) | -$342.84M(+2.9%) |
| Mar 2023 | - | -$58.98M(+48.5%) | -$353.17M(-49.5%) |
| Dec 2022 | - | -$114.43M(-12.9%) | -$236.21M(-25.0%) |
| Sep 2022 | -$188.91M(-227.9%) | -$101.38M(-29.3%) | -$188.91M(-57.6%) |
| Jun 2022 | - | -$78.38M(-235.2%) | -$119.85M(-59.8%) |
| Mar 2022 | - | $57.98M(+186.4%) | -$75.00M(-160.6%) |
| Dec 2021 | - | -$67.13M(-107.7%) | $123.72M(-16.2%) |
| Sep 2021 | $147.75M(+237.1%) | -$32.32M(+3.7%) | $147.66M(-11.7%) |
| Jun 2021 | - | -$33.54M(-113.1%) | $167.24M(+1.2%) |
| Mar 2021 | - | $256.71M(+694.3%) | $165.21M(+234.7%) |
| Dec 2020 | - | -$43.19M(-239.2%) | -$122.69M(-14.3%) |
| Sep 2020 | -$107.75M(-166.9%) | -$12.73M(+64.2%) | -$107.34M(-21.1%) |
| Jun 2020 | - | -$35.57M(-14.0%) | -$88.63M(-93.7%) |
| Mar 2020 | - | -$31.19M(-12.0%) | -$45.76M(-33.2%) |
| Dec 2019 | - | -$27.85M(-565.8%) | -$34.36M(-121.3%) |
| Sep 2019 | $161.03M(+431.0%) | $5.98M(-18.1%) | $161.03M(+6.2%) |
| Jun 2019 | - | $7.30M(+136.9%) | $151.66M(+16.9%) |
| Mar 2019 | - | -$19.80M(-111.8%) | $129.75M(-3.0%) |
| Dec 2018 | - | $167.55M(+5042.7%) | $133.73M(+374.9%) |
| Sep 2018 | -$48.64M(-52.7%) | -$3.39M(+76.8%) | -$48.64M(+10.9%) |
| Jun 2018 | - | -$14.61M(+7.7%) | -$54.57M(-5.9%) |
| Mar 2018 | - | -$15.82M(-6.7%) | -$51.53M(-0.3%) |
| Dec 2017 | - | -$14.83M(-59.2%) | -$51.39M(-61.3%) |
| Sep 2017 | -$31.86M(+53.3%) | -$9.31M(+19.5%) | -$31.86M(+10.1%) |
| Jun 2017 | - | -$11.57M(+26.2%) | -$35.44M(+17.3%) |
| Mar 2017 | - | -$15.68M(-433.4%) | -$42.87M(-2.0%) |
| Dec 2016 | - | $4.70M(+136.5%) | -$42.03M(+38.5%) |
| Sep 2016 | -$68.29M(-0.9%) | -$12.89M(+32.1%) | -$68.29M(-0.1%) |
| Jun 2016 | - | -$19.00M(-28.0%) | -$68.25M(-8.9%) |
| Mar 2016 | - | -$14.84M(+31.1%) | -$62.65M(+2.8%) |
| Dec 2015 | - | -$21.55M(-67.7%) | -$64.48M(+4.7%) |
| Sep 2015 | -$67.68M(-82.3%) | -$12.86M(+4.1%) | -$67.68M(-2.2%) |
| Jun 2015 | - | -$13.40M(+19.6%) | -$66.21M(-4.7%) |
| Mar 2015 | - | -$16.67M(+32.7%) | -$63.23M(-15.5%) |
| Dec 2014 | - | -$24.75M(-117.4%) | -$54.75M(-47.4%) |
| Sep 2014 | -$37.13M(-92.1%) | -$11.39M(-9.3%) | -$37.13M(-18.8%) |
| Jun 2014 | - | -$10.42M(-27.2%) | -$31.25M(-18.7%) |
| Mar 2014 | - | -$8.19M(-14.7%) | -$26.32M(-16.4%) |
| Dec 2013 | - | -$7.14M(-29.8%) | -$22.62M(-17.0%) |
| Sep 2013 | -$19.33M(-22.2%) | -$5.50M(-0.1%) | -$19.33M(-4.5%) |
| Jun 2013 | - | -$5.50M(-22.4%) | -$18.51M(-8.8%) |
| Mar 2013 | - | -$4.49M(-16.7%) | -$17.02M(-0.7%) |
| Dec 2012 | - | -$3.85M(+17.7%) | -$16.89M(-6.8%) |
| Sep 2012 | -$15.82M | -$4.67M(-16.7%) | -$15.82M(-23.5%) |
| Jun 2012 | - | -$4.01M(+8.2%) | -$12.81M(-31.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | -$4.36M(-57.3%) | -$9.77M(-8.4%) |
| Dec 2011 | - | -$2.77M(-66.9%) | -$9.02M(-17.6%) |
| Sep 2011 | -$5.40M(+29.9%) | -$1.66M(-71.3%) | -$7.67M(+10.2%) |
| Jun 2011 | - | -$970.80K(+73.1%) | -$8.54M(+8.6%) |
| Mar 2011 | - | -$3.61M(-153.5%) | -$9.34M(-24.4%) |
| Dec 2010 | - | -$1.42M(+43.9%) | -$7.51M(+2.5%) |
| Sep 2010 | -$7.70M(+49.7%) | -$2.54M(-43.1%) | -$7.70M(-1.6%) |
| Jun 2010 | - | -$1.77M(+0.1%) | -$7.58M(-3.8%) |
| Mar 2010 | - | -$1.78M(-9.7%) | -$7.30M(+22.8%) |
| Dec 2009 | - | -$1.62M(+33.0%) | -$9.46M(+38.2%) |
| Sep 2009 | -$15.32M(+45.8%) | -$2.42M(-61.5%) | -$15.32M(+28.6%) |
| Jun 2009 | - | -$1.50M(+61.9%) | -$21.46M(+22.7%) |
| Mar 2009 | - | -$3.93M(+47.4%) | -$27.77M(+6.6%) |
| Dec 2008 | - | -$7.48M(+12.6%) | -$29.75M(-5.2%) |
| Sep 2008 | -$28.27M(-14.8%) | -$8.56M(-9.6%) | -$28.27M(-7.1%) |
| Jun 2008 | - | -$7.81M(-32.3%) | -$26.40M(-7.1%) |
| Mar 2008 | - | -$5.90M(+1.6%) | -$24.64M(+3.1%) |
| Dec 2007 | - | -$6.00M(+10.3%) | -$25.42M(-3.2%) |
| Sep 2007 | -$24.62M(-56.6%) | -$6.69M(-10.6%) | -$24.62M(-8.0%) |
| Jun 2007 | - | -$6.05M(+9.5%) | -$22.80M(-10.7%) |
| Mar 2007 | - | -$6.68M(-28.3%) | -$20.59M(-18.0%) |
| Dec 2006 | - | -$5.21M(-7.0%) | -$17.44M(-12.4%) |
| Sep 2006 | -$15.73M(-60.9%) | -$4.86M(-26.7%) | -$15.52M(-17.5%) |
| Jun 2006 | - | -$3.84M(-8.7%) | -$13.21M(-5.3%) |
| Mar 2006 | - | -$3.53M(-7.5%) | -$12.54M(-16.8%) |
| Dec 2005 | - | -$3.29M(-28.9%) | -$10.73M(-9.8%) |
| Sep 2005 | -$9.77M(-227.9%) | -$2.55M(+19.7%) | -$9.77M(-16.8%) |
| Jun 2005 | - | -$3.17M(-83.8%) | -$8.37M(-34.4%) |
| Mar 2005 | - | -$1.73M(+25.7%) | -$6.22M(-24.9%) |
| Dec 2004 | - | -$2.32M(-103.2%) | -$4.98M(-67.3%) |
| Sep 2004 | -$2.98M(-1765.9%) | -$1.14M(-11.2%) | -$2.98M(-54.0%) |
| Jun 2004 | - | -$1.03M(-111.3%) | -$1.93M(-111.9%) |
| Mar 2004 | - | -$486.90K(-52.1%) | -$913.00K(-96.8%) |
| Dec 2003 | - | -$320.20K(-225.4%) | -$464.00K(-190.5%) |
| Sep 2003 | -$159.70K(-48.6%) | -$98.40K(-1212.0%) | -$159.70K(-111.8%) |
| Jun 2003 | - | -$7500.00(+80.2%) | -$75.40K(+35.5%) |
| Mar 2003 | - | -$37.90K(-138.4%) | -$116.90K(-21.0%) |
| Dec 2002 | - | -$15.90K(-12.8%) | -$96.60K(+10.2%) |
| Sep 2002 | -$107.50K(-31.4%) | -$14.10K(+71.2%) | -$107.60K(+0.6%) |
| Jun 2002 | - | -$49.00K(-178.4%) | -$108.20K(-45.0%) |
| Mar 2002 | - | -$17.60K(+34.6%) | -$74.60K(+17.0%) |
| Dec 2001 | - | -$26.90K(-83.0%) | -$89.90K(-9.8%) |
| Sep 2001 | -$81.80K(-1.2%) | -$14.70K(+4.5%) | -$81.90K(+7.2%) |
| Jun 2001 | - | -$15.40K(+53.2%) | -$88.30K(+34.3%) |
| Mar 2001 | - | -$32.90K(-74.1%) | -$134.30K(-33.9%) |
| Dec 2000 | - | -$18.90K(+10.4%) | -$100.30K(-24.0%) |
| Sep 2000 | -$80.80K(-129.5%) | -$21.10K(+65.6%) | -$80.90K(+76.2%) |
| Jun 2000 | - | -$61.40K(-5681.8%) | -$340.60K(-543.5%) |
| Mar 2000 | - | $1100.00(+120.0%) | $76.80K(+1.5%) |
| Dec 1999 | - | $500.00(+100.2%) | $75.70K(+0.7%) |
| Sep 1999 | -$35.20K(>-9900.0%) | -$280.80K(-178.9%) | $75.20K(-78.9%) |
| Jun 1999 | - | $356.00K | $356.00K |
| Sep 1998 | $100.00(-97.8%) | - | - |
| Sep 1997 | $4600.00 | - | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of ARWR is -$604.32M
What is the all-time high annual free cash flow for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual free cash flow is $161.03M
What is Arrowhead Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, ARWR annual free cash flow has changed by -$273.69M (-82.78%)
What is Arrowhead Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of ARWR is -$152.08M
What is the all-time high quarterly free cash flow for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly free cash flow is $454.76M
What is Arrowhead Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, ARWR quarterly free cash flow has changed by -$22.22M (-17.11%)
What is Arrowhead Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of ARWR is -$17.62M
What is the all-time high TTM free cash flow for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high TTM free cash flow is $167.24M
What is Arrowhead Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, ARWR TTM free cash flow has changed by +$514.36M (+96.69%)